nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—CYP2E1—type 2 diabetes mellitus	0.161	0.459	CbGaD
Rufinamide—CYP3A4—type 2 diabetes mellitus	0.102	0.289	CbGaD
Rufinamide—ALB—type 2 diabetes mellitus	0.0886	0.252	CbGaD
Rufinamide—ALB—Gliclazide—type 2 diabetes mellitus	0.0436	0.131	CbGbCtD
Rufinamide—ALB—Repaglinide—type 2 diabetes mellitus	0.041	0.124	CbGbCtD
Rufinamide—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0342	0.103	CbGbCtD
Rufinamide—ALB—Valsartan—type 2 diabetes mellitus	0.0302	0.0911	CbGbCtD
Rufinamide—ALB—Nateglinide—type 2 diabetes mellitus	0.0281	0.0847	CbGbCtD
Rufinamide—ALB—Glyburide—type 2 diabetes mellitus	0.019	0.0572	CbGbCtD
Rufinamide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.018	0.0543	CbGbCtD
Rufinamide—ALB—Losartan—type 2 diabetes mellitus	0.0174	0.0523	CbGbCtD
Rufinamide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0161	0.0484	CbGbCtD
Rufinamide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0147	0.0443	CbGbCtD
Rufinamide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0129	0.0387	CbGbCtD
Rufinamide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0116	0.035	CbGbCtD
Rufinamide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00881	0.0265	CbGbCtD
Rufinamide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00845	0.0254	CbGbCtD
Rufinamide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00845	0.0254	CbGbCtD
Rufinamide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00799	0.0241	CbGbCtD
Rufinamide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00595	0.0179	CbGbCtD
Rufinamide—CYP3A4—Losartan—type 2 diabetes mellitus	0.00544	0.0164	CbGbCtD
Rufinamide—SCN11A—peripheral nervous system—type 2 diabetes mellitus	0.00522	0.146	CbGeAlD
Rufinamide—SCN11A—nerve—type 2 diabetes mellitus	0.00407	0.114	CbGeAlD
Rufinamide—SCN8A—peripheral nervous system—type 2 diabetes mellitus	0.00396	0.111	CbGeAlD
Rufinamide—SCN8A—nerve—type 2 diabetes mellitus	0.00308	0.0865	CbGeAlD
Rufinamide—SCN10A—peripheral nervous system—type 2 diabetes mellitus	0.00265	0.0743	CbGeAlD
Rufinamide—SCN10A—nerve—type 2 diabetes mellitus	0.00206	0.0579	CbGeAlD
Rufinamide—SCN7A—cardiovascular system—type 2 diabetes mellitus	0.00121	0.034	CbGeAlD
Rufinamide—SCN7A—adipose tissue—type 2 diabetes mellitus	0.00107	0.03	CbGeAlD
Rufinamide—SCN9A—nephron tubule—type 2 diabetes mellitus	0.00106	0.0297	CbGeAlD
Rufinamide—SCN9A—adipose tissue—type 2 diabetes mellitus	0.000837	0.0235	CbGeAlD
Rufinamide—SCN4A—kidney—type 2 diabetes mellitus	0.000829	0.0233	CbGeAlD
Rufinamide—SCN10A—nephron tubule—type 2 diabetes mellitus	0.000805	0.0226	CbGeAlD
Rufinamide—CES1—cardiovascular system—type 2 diabetes mellitus	0.000756	0.0212	CbGeAlD
Rufinamide—SCN7A—liver—type 2 diabetes mellitus	0.00075	0.021	CbGeAlD
Rufinamide—SCN4A—adipose tissue—type 2 diabetes mellitus	0.000747	0.021	CbGeAlD
Rufinamide—SCN2A—cortex of kidney—type 2 diabetes mellitus	0.000714	0.02	CbGeAlD
Rufinamide—CES1—adipose tissue—type 2 diabetes mellitus	0.000667	0.0187	CbGeAlD
Rufinamide—SCN5A—cardiovascular system—type 2 diabetes mellitus	0.000657	0.0184	CbGeAlD
Rufinamide—SCN3A—kidney—type 2 diabetes mellitus	0.000645	0.0181	CbGeAlD
Rufinamide—SCN3A—cortex of kidney—type 2 diabetes mellitus	0.000628	0.0176	CbGeAlD
Rufinamide—SCN3A—adipose tissue—type 2 diabetes mellitus	0.000581	0.0163	CbGeAlD
Rufinamide—CES1—liver—type 2 diabetes mellitus	0.000468	0.0131	CbGeAlD
Rufinamide—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000346	0.00972	CbGeAlD
Rufinamide—ALB—liver—type 2 diabetes mellitus	0.000325	0.00913	CbGeAlD
Rufinamide—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000311	0.00873	CbGeAlD
Rufinamide—CYP2E1—kidney—type 2 diabetes mellitus	0.000304	0.00854	CbGeAlD
Rufinamide—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000296	0.00832	CbGeAlD
Rufinamide—CYP3A4—kidney—type 2 diabetes mellitus	0.000245	0.00687	CbGeAlD
Rufinamide—CYP2E1—liver—type 2 diabetes mellitus	0.000192	0.0054	CbGeAlD
Rufinamide—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000183	0.00111	CcSEcCtD
Rufinamide—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000183	0.0011	CcSEcCtD
Rufinamide—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000182	0.0011	CcSEcCtD
Rufinamide—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000182	0.0011	CcSEcCtD
Rufinamide—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000181	0.0011	CcSEcCtD
Rufinamide—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000181	0.0011	CcSEcCtD
Rufinamide—Nausea—Repaglinide—type 2 diabetes mellitus	0.000181	0.0011	CcSEcCtD
Rufinamide—Asthenia—Glipizide—type 2 diabetes mellitus	0.000181	0.00109	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000181	0.00109	CcSEcCtD
Rufinamide—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00018	0.00109	CcSEcCtD
Rufinamide—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.00018	0.00109	CcSEcCtD
Rufinamide—Malnutrition—Metformin—type 2 diabetes mellitus	0.000179	0.00108	CcSEcCtD
Rufinamide—Pruritus—Glipizide—type 2 diabetes mellitus	0.000178	0.00108	CcSEcCtD
Rufinamide—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000178	0.00108	CcSEcCtD
Rufinamide—Vertigo—Valsartan—type 2 diabetes mellitus	0.000176	0.00107	CcSEcCtD
Rufinamide—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000175	0.00106	CcSEcCtD
Rufinamide—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000175	0.00106	CcSEcCtD
Rufinamide—Vertigo—Orlistat—type 2 diabetes mellitus	0.000174	0.00105	CcSEcCtD
Rufinamide—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000173	0.00105	CcSEcCtD
Rufinamide—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000173	0.00105	CcSEcCtD
Rufinamide—Infection—Gliclazide—type 2 diabetes mellitus	0.000173	0.00105	CcSEcCtD
Rufinamide—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000173	0.00105	CcSEcCtD
Rufinamide—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000173	0.00104	CcSEcCtD
Rufinamide—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000171	0.00104	CcSEcCtD
Rufinamide—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000171	0.00103	CcSEcCtD
Rufinamide—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000171	0.00103	CcSEcCtD
Rufinamide—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000171	0.00103	CcSEcCtD
Rufinamide—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000169	0.00102	CcSEcCtD
Rufinamide—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000169	0.00102	CcSEcCtD
Rufinamide—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000169	0.00102	CcSEcCtD
Rufinamide—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000169	0.00102	CcSEcCtD
Rufinamide—Vision blurred—Metformin—type 2 diabetes mellitus	0.000168	0.00102	CcSEcCtD
Rufinamide—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000168	0.00102	CcSEcCtD
Rufinamide—Convulsion—Orlistat—type 2 diabetes mellitus	0.000168	0.00102	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000168	0.00101	CcSEcCtD
Rufinamide—Tremor—Metformin—type 2 diabetes mellitus	0.000167	0.00101	CcSEcCtD
Rufinamide—Dizziness—Glipizide—type 2 diabetes mellitus	0.000167	0.00101	CcSEcCtD
Rufinamide—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000166	0.00101	CcSEcCtD
Rufinamide—Anxiety—Valsartan—type 2 diabetes mellitus	0.000166	0.00101	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000166	0.001	CcSEcCtD
Rufinamide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000165	0.001	CcSEcCtD
Rufinamide—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000165	0.000996	CcSEcCtD
Rufinamide—Anxiety—Orlistat—type 2 diabetes mellitus	0.000164	0.000995	CcSEcCtD
Rufinamide—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000164	0.000993	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000164	0.000992	CcSEcCtD
Rufinamide—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000163	0.000988	CcSEcCtD
Rufinamide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000161	0.000974	CcSEcCtD
Rufinamide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00016	0.000971	CcSEcCtD
Rufinamide—Vomiting—Glipizide—type 2 diabetes mellitus	0.00016	0.00097	CcSEcCtD
Rufinamide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00016	0.000967	CcSEcCtD
Rufinamide—Infection—Valsartan—type 2 diabetes mellitus	0.000159	0.000962	CcSEcCtD
Rufinamide—Rash—Glipizide—type 2 diabetes mellitus	0.000159	0.000962	CcSEcCtD
Rufinamide—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000159	0.000961	CcSEcCtD
Rufinamide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000159	0.000961	CcSEcCtD
Rufinamide—Headache—Glipizide—type 2 diabetes mellitus	0.000158	0.000956	CcSEcCtD
Rufinamide—Tremor—Irbesartan—type 2 diabetes mellitus	0.000158	0.000956	CcSEcCtD
Rufinamide—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000158	0.000954	CcSEcCtD
Rufinamide—Infection—Orlistat—type 2 diabetes mellitus	0.000157	0.000951	CcSEcCtD
Rufinamide—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000157	0.00095	CcSEcCtD
Rufinamide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000157	0.000948	CcSEcCtD
Rufinamide—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000156	0.000943	CcSEcCtD
Rufinamide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000156	0.000942	CcSEcCtD
Rufinamide—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000156	0.000941	CcSEcCtD
Rufinamide—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000155	0.000939	CcSEcCtD
Rufinamide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000155	0.000939	CcSEcCtD
Rufinamide—Agitation—Irbesartan—type 2 diabetes mellitus	0.000155	0.000937	CcSEcCtD
Rufinamide—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000155	0.000937	CcSEcCtD
Rufinamide—CYP3A4—liver—type 2 diabetes mellitus	0.000155	0.00434	CbGeAlD
Rufinamide—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000154	0.00093	CcSEcCtD
Rufinamide—Back pain—Losartan—type 2 diabetes mellitus	0.000153	0.000929	CcSEcCtD
Rufinamide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000153	0.000928	CcSEcCtD
Rufinamide—Anorexia—Valsartan—type 2 diabetes mellitus	0.000153	0.000923	CcSEcCtD
Rufinamide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000152	0.000922	CcSEcCtD
Rufinamide—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000151	0.000916	CcSEcCtD
Rufinamide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000151	0.000916	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000151	0.000914	CcSEcCtD
Rufinamide—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000151	0.000913	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00015	0.00091	CcSEcCtD
Rufinamide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00015	0.000909	CcSEcCtD
Rufinamide—Nausea—Glipizide—type 2 diabetes mellitus	0.00015	0.000906	CcSEcCtD
Rufinamide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00015	0.000905	CcSEcCtD
Rufinamide—Vision blurred—Losartan—type 2 diabetes mellitus	0.00015	0.000905	CcSEcCtD
Rufinamide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000149	0.000902	CcSEcCtD
Rufinamide—Constipation—Gliclazide—type 2 diabetes mellitus	0.000149	0.000902	CcSEcCtD
Rufinamide—Tremor—Losartan—type 2 diabetes mellitus	0.000149	0.000899	CcSEcCtD
Rufinamide—Rash—Glimepiride—type 2 diabetes mellitus	0.000148	0.000898	CcSEcCtD
Rufinamide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000148	0.000897	CcSEcCtD
Rufinamide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000148	0.000895	CcSEcCtD
Rufinamide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000148	0.000894	CcSEcCtD
Rufinamide—Headache—Glimepiride—type 2 diabetes mellitus	0.000147	0.000892	CcSEcCtD
Rufinamide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000147	0.000889	CcSEcCtD
Rufinamide—Anaemia—Losartan—type 2 diabetes mellitus	0.000147	0.000887	CcSEcCtD
Rufinamide—Agitation—Losartan—type 2 diabetes mellitus	0.000146	0.000882	CcSEcCtD
Rufinamide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000145	0.000879	CcSEcCtD
Rufinamide—Infection—Metformin—type 2 diabetes mellitus	0.000145	0.000876	CcSEcCtD
Rufinamide—Insomnia—Valsartan—type 2 diabetes mellitus	0.000145	0.000876	CcSEcCtD
Rufinamide—Insomnia—Orlistat—type 2 diabetes mellitus	0.000143	0.000866	CcSEcCtD
Rufinamide—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000143	0.000865	CcSEcCtD
Rufinamide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000143	0.000865	CcSEcCtD
Rufinamide—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000143	0.000865	CcSEcCtD
Rufinamide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000143	0.000864	CcSEcCtD
Rufinamide—Vertigo—Losartan—type 2 diabetes mellitus	0.000143	0.000862	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000143	0.000862	CcSEcCtD
Rufinamide—Somnolence—Valsartan—type 2 diabetes mellitus	0.000142	0.000861	CcSEcCtD
Rufinamide—Leukopenia—Losartan—type 2 diabetes mellitus	0.000142	0.000859	CcSEcCtD
Rufinamide—Skin disorder—Metformin—type 2 diabetes mellitus	0.000142	0.000857	CcSEcCtD
Rufinamide—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000141	0.000854	CcSEcCtD
Rufinamide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000141	0.000853	CcSEcCtD
Rufinamide—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000141	0.000852	CcSEcCtD
Rufinamide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00014	0.000849	CcSEcCtD
Rufinamide—Nausea—Glimepiride—type 2 diabetes mellitus	0.00014	0.000846	CcSEcCtD
Rufinamide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000139	0.000843	CcSEcCtD
Rufinamide—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000139	0.000843	CcSEcCtD
Rufinamide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000139	0.000842	CcSEcCtD
Rufinamide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000139	0.000842	CcSEcCtD
Rufinamide—Anorexia—Metformin—type 2 diabetes mellitus	0.000139	0.000841	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000138	0.000836	CcSEcCtD
Rufinamide—Fatigue—Valsartan—type 2 diabetes mellitus	0.000138	0.000835	CcSEcCtD
Rufinamide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000138	0.000832	CcSEcCtD
Rufinamide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000137	0.000831	CcSEcCtD
Rufinamide—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000137	0.000828	CcSEcCtD
Rufinamide—Constipation—Valsartan—type 2 diabetes mellitus	0.000137	0.000828	CcSEcCtD
Rufinamide—Infection—Irbesartan—type 2 diabetes mellitus	0.000137	0.000827	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000137	0.000826	CcSEcCtD
Rufinamide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000136	0.000825	CcSEcCtD
Rufinamide—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000136	0.000823	CcSEcCtD
Rufinamide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000135	0.000817	CcSEcCtD
Rufinamide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000135	0.000816	CcSEcCtD
Rufinamide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000135	0.000815	CcSEcCtD
Rufinamide—Anxiety—Losartan—type 2 diabetes mellitus	0.000135	0.000814	CcSEcCtD
Rufinamide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000134	0.00081	CcSEcCtD
Rufinamide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000134	0.000809	CcSEcCtD
Rufinamide—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000134	0.000809	CcSEcCtD
Rufinamide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000133	0.000805	CcSEcCtD
Rufinamide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000133	0.000803	CcSEcCtD
Rufinamide—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000131	0.000794	CcSEcCtD
Rufinamide—Somnolence—Metformin—type 2 diabetes mellitus	0.00013	0.000784	CcSEcCtD
Rufinamide—Infection—Losartan—type 2 diabetes mellitus	0.000129	0.000778	CcSEcCtD
Rufinamide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000128	0.000777	CcSEcCtD
Rufinamide—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000128	0.000777	CcSEcCtD
Rufinamide—Tremor—Ramipril—type 2 diabetes mellitus	0.000127	0.000771	CcSEcCtD
Rufinamide—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000127	0.000768	CcSEcCtD
Rufinamide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000127	0.000767	CcSEcCtD
Rufinamide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000127	0.000767	CcSEcCtD
Rufinamide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000126	0.000763	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000126	0.000762	CcSEcCtD
Rufinamide—Fatigue—Metformin—type 2 diabetes mellitus	0.000126	0.000761	CcSEcCtD
Rufinamide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000125	0.000756	CcSEcCtD
Rufinamide—Agitation—Ramipril—type 2 diabetes mellitus	0.000125	0.000756	CcSEcCtD
Rufinamide—Constipation—Metformin—type 2 diabetes mellitus	0.000125	0.000754	CcSEcCtD
Rufinamide—Anorexia—Losartan—type 2 diabetes mellitus	0.000123	0.000747	CcSEcCtD
Rufinamide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000123	0.000747	CcSEcCtD
Rufinamide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000123	0.000746	CcSEcCtD
Rufinamide—Rash—Glyburide—type 2 diabetes mellitus	0.000122	0.00074	CcSEcCtD
Rufinamide—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000122	0.00074	CcSEcCtD
Rufinamide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000122	0.00074	CcSEcCtD
Rufinamide—Vertigo—Ramipril—type 2 diabetes mellitus	0.000122	0.00074	CcSEcCtD
Rufinamide—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000122	0.000737	CcSEcCtD
Rufinamide—Headache—Glyburide—type 2 diabetes mellitus	0.000122	0.000736	CcSEcCtD
Rufinamide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000121	0.000733	CcSEcCtD
Rufinamide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.00012	0.000724	CcSEcCtD
Rufinamide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000119	0.000721	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000119	0.000719	CcSEcCtD
Rufinamide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000119	0.000718	CcSEcCtD
Rufinamide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000118	0.000714	CcSEcCtD
Rufinamide—Convulsion—Ramipril—type 2 diabetes mellitus	0.000118	0.000713	CcSEcCtD
Rufinamide—Constipation—Irbesartan—type 2 diabetes mellitus	0.000118	0.000712	CcSEcCtD
Rufinamide—Insomnia—Losartan—type 2 diabetes mellitus	0.000117	0.000709	CcSEcCtD
Rufinamide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000117	0.000705	CcSEcCtD
Rufinamide—Anxiety—Ramipril—type 2 diabetes mellitus	0.000115	0.000698	CcSEcCtD
Rufinamide—Nausea—Glyburide—type 2 diabetes mellitus	0.000115	0.000697	CcSEcCtD
Rufinamide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000115	0.000697	CcSEcCtD
Rufinamide—Somnolence—Losartan—type 2 diabetes mellitus	0.000115	0.000696	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000115	0.000696	CcSEcCtD
Rufinamide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000115	0.000695	CcSEcCtD
Rufinamide—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000114	0.00069	CcSEcCtD
Rufinamide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000114	0.000687	CcSEcCtD
Rufinamide—Pruritus—Valsartan—type 2 diabetes mellitus	0.000113	0.000685	CcSEcCtD
Rufinamide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000113	0.000681	CcSEcCtD
Rufinamide—Pruritus—Orlistat—type 2 diabetes mellitus	0.000112	0.000677	CcSEcCtD
Rufinamide—Fatigue—Losartan—type 2 diabetes mellitus	0.000112	0.000675	CcSEcCtD
Rufinamide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000111	0.00067	CcSEcCtD
Rufinamide—Constipation—Losartan—type 2 diabetes mellitus	0.000111	0.00067	CcSEcCtD
Rufinamide—Rash—Gliclazide—type 2 diabetes mellitus	0.00011	0.000665	CcSEcCtD
Rufinamide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00011	0.000664	CcSEcCtD
Rufinamide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00011	0.000663	CcSEcCtD
Rufinamide—Headache—Gliclazide—type 2 diabetes mellitus	0.000109	0.000661	CcSEcCtD
Rufinamide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000109	0.000659	CcSEcCtD
Rufinamide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000109	0.000658	CcSEcCtD
Rufinamide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000108	0.000655	CcSEcCtD
Rufinamide—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000108	0.000653	CcSEcCtD
Rufinamide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000106	0.000641	CcSEcCtD
Rufinamide—Anorexia—Ramipril—type 2 diabetes mellitus	0.000106	0.00064	CcSEcCtD
Rufinamide—Dizziness—Orlistat—type 2 diabetes mellitus	0.000105	0.000633	CcSEcCtD
Rufinamide—Asthenia—Metformin—type 2 diabetes mellitus	0.000105	0.000633	CcSEcCtD
Rufinamide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000104	0.000626	CcSEcCtD
Rufinamide—Pruritus—Metformin—type 2 diabetes mellitus	0.000103	0.000624	CcSEcCtD
Rufinamide—Vomiting—Valsartan—type 2 diabetes mellitus	0.000102	0.000616	CcSEcCtD
Rufinamide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000101	0.000613	CcSEcCtD
Rufinamide—Rash—Valsartan—type 2 diabetes mellitus	0.000101	0.000611	CcSEcCtD
Rufinamide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000101	0.00061	CcSEcCtD
Rufinamide—Vomiting—Orlistat—type 2 diabetes mellitus	0.000101	0.000609	CcSEcCtD
Rufinamide—Insomnia—Ramipril—type 2 diabetes mellitus	0.0001	0.000608	CcSEcCtD
Rufinamide—Headache—Valsartan—type 2 diabetes mellitus	0.0001	0.000607	CcSEcCtD
Rufinamide—Diarrhoea—Metformin—type 2 diabetes mellitus	9.98e-05	0.000604	CcSEcCtD
Rufinamide—Rash—Orlistat—type 2 diabetes mellitus	9.97e-05	0.000604	CcSEcCtD
Rufinamide—Dermatitis—Orlistat—type 2 diabetes mellitus	9.97e-05	0.000603	CcSEcCtD
Rufinamide—Headache—Orlistat—type 2 diabetes mellitus	9.91e-05	0.0006	CcSEcCtD
Rufinamide—Asthenia—Irbesartan—type 2 diabetes mellitus	9.87e-05	0.000597	CcSEcCtD
Rufinamide—Somnolence—Ramipril—type 2 diabetes mellitus	9.87e-05	0.000597	CcSEcCtD
Rufinamide—Dyspepsia—Ramipril—type 2 diabetes mellitus	9.77e-05	0.000591	CcSEcCtD
Rufinamide—Pruritus—Irbesartan—type 2 diabetes mellitus	9.73e-05	0.000589	CcSEcCtD
Rufinamide—Decreased appetite—Ramipril—type 2 diabetes mellitus	9.65e-05	0.000584	CcSEcCtD
Rufinamide—Dizziness—Metformin—type 2 diabetes mellitus	9.64e-05	0.000583	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	9.58e-05	0.00058	CcSEcCtD
Rufinamide—Fatigue—Ramipril—type 2 diabetes mellitus	9.57e-05	0.000579	CcSEcCtD
Rufinamide—Hypersensitivity—Losartan—type 2 diabetes mellitus	9.54e-05	0.000577	CcSEcCtD
Rufinamide—Nausea—Valsartan—type 2 diabetes mellitus	9.51e-05	0.000575	CcSEcCtD
Rufinamide—Constipation—Ramipril—type 2 diabetes mellitus	9.49e-05	0.000574	CcSEcCtD
Rufinamide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	9.41e-05	0.00057	CcSEcCtD
Rufinamide—Nausea—Orlistat—type 2 diabetes mellitus	9.4e-05	0.000569	CcSEcCtD
Rufinamide—Asthenia—Losartan—type 2 diabetes mellitus	9.29e-05	0.000562	CcSEcCtD
Rufinamide—Vomiting—Metformin—type 2 diabetes mellitus	9.27e-05	0.000561	CcSEcCtD
Rufinamide—Rash—Metformin—type 2 diabetes mellitus	9.19e-05	0.000556	CcSEcCtD
Rufinamide—Dermatitis—Metformin—type 2 diabetes mellitus	9.18e-05	0.000556	CcSEcCtD
Rufinamide—Pruritus—Losartan—type 2 diabetes mellitus	9.16e-05	0.000554	CcSEcCtD
Rufinamide—Headache—Metformin—type 2 diabetes mellitus	9.13e-05	0.000553	CcSEcCtD
Rufinamide—Dizziness—Irbesartan—type 2 diabetes mellitus	9.1e-05	0.000551	CcSEcCtD
Rufinamide—Diarrhoea—Losartan—type 2 diabetes mellitus	8.86e-05	0.000536	CcSEcCtD
Rufinamide—Vomiting—Irbesartan—type 2 diabetes mellitus	8.75e-05	0.000529	CcSEcCtD
Rufinamide—Rash—Irbesartan—type 2 diabetes mellitus	8.67e-05	0.000525	CcSEcCtD
Rufinamide—Dermatitis—Irbesartan—type 2 diabetes mellitus	8.67e-05	0.000524	CcSEcCtD
Rufinamide—Nausea—Metformin—type 2 diabetes mellitus	8.66e-05	0.000524	CcSEcCtD
Rufinamide—Headache—Irbesartan—type 2 diabetes mellitus	8.62e-05	0.000522	CcSEcCtD
Rufinamide—Dizziness—Losartan—type 2 diabetes mellitus	8.56e-05	0.000518	CcSEcCtD
Rufinamide—Vomiting—Losartan—type 2 diabetes mellitus	8.23e-05	0.000498	CcSEcCtD
Rufinamide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000495	CcSEcCtD
Rufinamide—Nausea—Irbesartan—type 2 diabetes mellitus	8.17e-05	0.000494	CcSEcCtD
Rufinamide—Rash—Losartan—type 2 diabetes mellitus	8.16e-05	0.000494	CcSEcCtD
Rufinamide—Dermatitis—Losartan—type 2 diabetes mellitus	8.16e-05	0.000494	CcSEcCtD
Rufinamide—Headache—Losartan—type 2 diabetes mellitus	8.11e-05	0.000491	CcSEcCtD
Rufinamide—Asthenia—Ramipril—type 2 diabetes mellitus	7.97e-05	0.000482	CcSEcCtD
Rufinamide—Pruritus—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000475	CcSEcCtD
Rufinamide—Nausea—Losartan—type 2 diabetes mellitus	7.69e-05	0.000465	CcSEcCtD
Rufinamide—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.6e-05	0.00046	CcSEcCtD
Rufinamide—Dizziness—Ramipril—type 2 diabetes mellitus	7.34e-05	0.000444	CcSEcCtD
Rufinamide—Vomiting—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000427	CcSEcCtD
Rufinamide—Rash—Ramipril—type 2 diabetes mellitus	7e-05	0.000424	CcSEcCtD
Rufinamide—Dermatitis—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000423	CcSEcCtD
Rufinamide—Headache—Ramipril—type 2 diabetes mellitus	6.96e-05	0.000421	CcSEcCtD
Rufinamide—Nausea—Ramipril—type 2 diabetes mellitus	6.59e-05	0.000399	CcSEcCtD
Rufinamide—SCN1A—Developmental Biology—AKT1—type 2 diabetes mellitus	8.82e-06	7.64e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ACACA—type 2 diabetes mellitus	8.77e-06	7.59e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—STAR—type 2 diabetes mellitus	8.77e-06	7.59e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HSD17B3—type 2 diabetes mellitus	8.77e-06	7.59e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	8.77e-06	7.59e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EGFR—type 2 diabetes mellitus	8.75e-06	7.57e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—GNB3—type 2 diabetes mellitus	8.73e-06	7.56e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IGF2—type 2 diabetes mellitus	8.58e-06	7.42e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PCK1—type 2 diabetes mellitus	8.55e-06	7.41e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCC8—type 2 diabetes mellitus	8.41e-06	7.28e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CBS—type 2 diabetes mellitus	8.41e-06	7.28e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TNF—type 2 diabetes mellitus	8.33e-06	7.21e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—APOB—type 2 diabetes mellitus	8.33e-06	7.21e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.11e-06	7.02e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC5A2—type 2 diabetes mellitus	8.1e-06	7.01e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—COX2—type 2 diabetes mellitus	8.1e-06	7.01e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HK1—type 2 diabetes mellitus	8.01e-06	6.93e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	7.95e-06	6.89e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	7.95e-06	6.88e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.95e-06	6.88e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	7.91e-06	6.84e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—UCP2—type 2 diabetes mellitus	7.82e-06	6.77e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—UCP3—type 2 diabetes mellitus	7.82e-06	6.77e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	7.82e-06	6.77e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HSD3B2—type 2 diabetes mellitus	7.74e-06	6.7e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—KCNJ11—type 2 diabetes mellitus	7.74e-06	6.7e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—LPA—type 2 diabetes mellitus	7.74e-06	6.7e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GCKR—type 2 diabetes mellitus	7.74e-06	6.7e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	7.58e-06	6.56e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	7.56e-06	6.54e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CD36—type 2 diabetes mellitus	7.55e-06	6.54e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	7.52e-06	6.51e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	7.46e-06	6.46e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	7.46e-06	6.46e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALDOB—type 2 diabetes mellitus	7.42e-06	6.42e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PCK1—type 2 diabetes mellitus	7.35e-06	6.36e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	7.24e-06	6.27e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	7.21e-06	6.24e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	7.16e-06	6.2e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	7.06e-06	6.11e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	6.98e-06	6.04e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	6.91e-06	5.98e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	6.91e-06	5.98e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GLP1R—type 2 diabetes mellitus	6.9e-06	5.97e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	6.89e-06	5.96e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HK1—type 2 diabetes mellitus	6.88e-06	5.96e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	6.88e-06	5.95e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	6.74e-06	5.83e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—IL6—type 2 diabetes mellitus	6.72e-06	5.82e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	6.69e-06	5.79e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—LPA—type 2 diabetes mellitus	6.65e-06	5.76e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	6.65e-06	5.76e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GCKR—type 2 diabetes mellitus	6.65e-06	5.76e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	6.65e-06	5.76e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	6.59e-06	5.7e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	6.55e-06	5.67e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	6.55e-06	5.67e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC2A2—type 2 diabetes mellitus	6.44e-06	5.57e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	6.4e-06	5.54e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.39e-06	5.53e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	6.37e-06	5.52e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CPT1A—type 2 diabetes mellitus	6.31e-06	5.46e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MTR—type 2 diabetes mellitus	6.31e-06	5.46e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	6.28e-06	5.44e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	6.25e-06	5.41e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	6.21e-06	5.38e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT1—type 2 diabetes mellitus	6.2e-06	5.37e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.19e-06	5.36e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NAMPT—type 2 diabetes mellitus	6.18e-06	5.35e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HBA1—type 2 diabetes mellitus	6.15e-06	5.32e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—LIPC—type 2 diabetes mellitus	6.15e-06	5.32e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GCK—type 2 diabetes mellitus	6.15e-06	5.32e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	6.11e-06	5.29e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP11A1—type 2 diabetes mellitus	6.11e-06	5.29e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	6.08e-06	5.26e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.07e-06	5.25e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC9A1—type 2 diabetes mellitus	6e-06	5.19e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6e-06	5.19e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CETP—type 2 diabetes mellitus	5.93e-06	5.13e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	5.93e-06	5.13e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	5.77e-06	4.99e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	5.77e-06	4.99e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.7e-06	4.94e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.63e-06	4.88e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	5.57e-06	4.82e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	5.57e-06	4.82e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	5.57e-06	4.82e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	5.57e-06	4.82e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	5.57e-06	4.82e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	5.53e-06	4.79e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SREBF1—type 2 diabetes mellitus	5.51e-06	4.77e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SNAP25—type 2 diabetes mellitus	5.51e-06	4.77e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PSMD6—type 2 diabetes mellitus	5.51e-06	4.77e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	5.51e-06	4.77e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	5.5e-06	4.76e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTR—type 2 diabetes mellitus	5.42e-06	4.69e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	5.42e-06	4.69e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CTGF—type 2 diabetes mellitus	5.41e-06	4.68e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	5.39e-06	4.67e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HMGCR—type 2 diabetes mellitus	5.36e-06	4.64e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	5.32e-06	4.6e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.28e-06	4.57e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—LIPC—type 2 diabetes mellitus	5.28e-06	4.57e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GCK—type 2 diabetes mellitus	5.28e-06	4.57e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HBA1—type 2 diabetes mellitus	5.28e-06	4.57e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	5.25e-06	4.54e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ADRA2A—type 2 diabetes mellitus	5.25e-06	4.54e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	5.23e-06	4.53e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	5.16e-06	4.46e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CETP—type 2 diabetes mellitus	5.1e-06	4.41e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	5.09e-06	4.41e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	5.09e-06	4.41e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	4.99e-06	4.32e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	4.99e-06	4.32e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.99e-06	4.32e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.99e-06	4.32e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	4.96e-06	4.3e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.86e-06	4.21e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.78e-06	4.14e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GCG—type 2 diabetes mellitus	4.78e-06	4.14e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	4.74e-06	4.1e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	4.74e-06	4.1e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	4.74e-06	4.1e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	4.74e-06	4.1e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	4.74e-06	4.1e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	4.74e-06	4.1e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CTGF—type 2 diabetes mellitus	4.65e-06	4.03e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	4.61e-06	3.99e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.55e-06	3.93e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	4.54e-06	3.93e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	4.54e-06	3.93e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	4.51e-06	3.9e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	4.45e-06	3.85e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	4.37e-06	3.78e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	4.37e-06	3.78e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	4.33e-06	3.75e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	4.29e-06	3.72e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	4.28e-06	3.71e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	4.28e-06	3.71e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.22e-06	3.65e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.22e-06	3.65e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.22e-06	3.65e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	4.18e-06	3.62e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.16e-06	3.6e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	4.12e-06	3.57e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.12e-06	3.57e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	4.11e-06	3.56e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GCG—type 2 diabetes mellitus	4.11e-06	3.56e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	4.1e-06	3.55e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	4.05e-06	3.5e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	3.97e-06	3.44e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	3.93e-06	3.4e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	3.82e-06	3.31e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	3.75e-06	3.25e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	3.72e-06	3.22e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SRC—type 2 diabetes mellitus	3.69e-06	3.2e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	3.67e-06	3.18e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	3.66e-06	3.17e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	3.6e-06	3.11e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.59e-06	3.11e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.59e-06	3.11e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.59e-06	3.11e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.59e-06	3.11e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	3.56e-06	3.08e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.54e-06	3.06e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GNB3—type 2 diabetes mellitus	3.54e-06	3.06e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	3.52e-06	3.05e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.52e-06	3.05e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CAT—type 2 diabetes mellitus	3.48e-06	3.01e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.44e-06	2.98e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	3.38e-06	2.92e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APOB—type 2 diabetes mellitus	3.38e-06	2.92e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	3.31e-06	2.87e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	3.3e-06	2.86e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	3.28e-06	2.84e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—LPL—type 2 diabetes mellitus	3.22e-06	2.79e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	3.21e-06	2.78e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.2e-06	2.77e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	3.16e-06	2.73e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	3.15e-06	2.73e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GPX1—type 2 diabetes mellitus	3.14e-06	2.72e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	3.14e-06	2.72e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	3.11e-06	2.69e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CD36—type 2 diabetes mellitus	3.06e-06	2.65e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	3.02e-06	2.62e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.99e-06	2.59e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.93e-06	2.53e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.93e-06	2.53e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	2.9e-06	2.51e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.87e-06	2.48e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.85e-06	2.47e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.85e-06	2.47e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.85e-06	2.47e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPARA—type 2 diabetes mellitus	2.85e-06	2.46e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.83e-06	2.45e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.78e-06	2.41e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AGT—type 2 diabetes mellitus	2.76e-06	2.39e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.75e-06	2.38e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	2.74e-06	2.37e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CALM1—type 2 diabetes mellitus	2.71e-06	2.35e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APOE—type 2 diabetes mellitus	2.7e-06	2.34e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	2.69e-06	2.32e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APOA1—type 2 diabetes mellitus	2.67e-06	2.31e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.56e-06	2.21e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.56e-06	2.21e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.56e-06	2.21e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.51e-06	2.17e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.49e-06	2.15e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	2.46e-06	2.13e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.43e-06	2.11e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.36e-06	2.04e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.36e-06	2.04e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPARG—type 2 diabetes mellitus	2.35e-06	2.04e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.34e-06	2.02e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.31e-06	2e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.31e-06	2e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—INS—type 2 diabetes mellitus	2.31e-06	2e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	2.29e-06	1.99e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.22e-06	1.92e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.22e-06	1.92e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	2.15e-06	1.86e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NOS3—type 2 diabetes mellitus	2.02e-06	1.75e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.02e-06	1.75e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.91e-06	1.65e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.91e-06	1.65e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.9e-06	1.65e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.88e-06	1.62e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	1.85e-06	1.6e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.82e-06	1.58e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.77e-06	1.53e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.74e-06	1.51e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.7e-06	1.47e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.7e-06	1.47e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.65e-06	1.43e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.63e-06	1.41e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.57e-06	1.36e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.54e-06	1.33e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.49e-06	1.29e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.46e-06	1.27e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.46e-06	1.26e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.44e-06	1.25e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.27e-06	1.1e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.25e-06	1.08e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.14e-06	9.89e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.09e-06	9.46e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.09e-06	9.46e-06	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	9.37e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	9.99e-07	8.65e-06	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKT1—type 2 diabetes mellitus	9.3e-07	8.05e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.02e-07	4.35e-06	CbGpPWpGaD
